L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons

Stroke

Volumn 29, Issue 1, 1998, Pages 196-202

  Pisani, Antonio ^a   Calabresi, Paolo ^a   Tozzi, Alessandro ^a   D'Angelo, Vincenza ^a   Bernardi, Giorgio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Calcium channels; Electrophysiology; Fura 2; Glucose; Ischemia; Oxygen

Indexed keywords

BIOCYTIN; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DANTROLENE; FURA 2; GLUCOSE; GLUTAMATE RECEPTOR ANTAGONIST; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; NIFEDIPINE; NIMODIPINE; OXYGEN; TETRODOTOXIN; AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM; DIAGNOSTIC AGENT; FLUORESCENT DYE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HYPERPOLARIZATION; MAJOR CLINICAL STUDY; MALE; MICROFLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING; SYNAPTIC INHIBITION; ANIMAL; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CLASSIFICATION; CYTOPHOTOMETRY; DRUG EFFECT; ENERGY METABOLISM; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL MEMBRANE; CYTOPHOTOMETRY; DANTROLENE; ENERGY METABOLISM; EXCITATORY AMINO ACID ANTAGONISTS; FLUORESCENT DYES; FURA-2; GLUCOSE; MALE; MEMBRANE POTENTIALS; NIFEDIPINE; NIMODIPINE; OXYGEN CONSUMPTION; PYRAMIDAL CELLS; RATS; RATS, WISTAR; TETRODOTOXIN; TIME FACTORS;

EID: 0031606341     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.1.196     Document Type: Article

References (47)

1. Martin RL, Lloyd HGE, Cowan AI. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 1994;17:251-257.
2. Mercuri NB, Bonci A, Johnson SW, Stratta F, Calabresi P, Bernardi P. Effects ot anoxia on rat midbrain dopamine neurons. J Neurophysiol. 1994; 71:1165-1173.
3. Krnjevic K, Leblond J. Changes in membrane currents of hippocampal neurons evoked by brief anoxia. J Neurophysiol. 1989;62:15-30.
4. Haddad GG, Jiang C. Mechanisms of anoxia-induced depolarization in brainstem neurons: in vitro current and voltage clamp studies in the adult rat. Brain Res. 1993;625:261-263.
5. Calabresi P, Pisani A, Mercuri NB, Bernardi G. On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain. 1995;118:1027-1038.
6. Jiang C, Haddad GG. Differential responses of neocortical neurons to glucose and/or O2 deprivation in the human and in the rat. J Neurophysiol. 1992;68:2165-2173.
7. 2+ measurements. Neuroreport. 1997;8: 1143-1147.
8. Siesjo BK. Historical overview: calcium, ischemia and death of brain cells. Ann N Y Acad Sci. 1988;522:638-661.
9. Choi DW. Ionic dependence of glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:369-379.
10. 2+) in hypoxia and ischemia in rat brain in vivo. J Gen Physiol. 1990;95:837-866.
11. Lipton P. Regulation of glycogen in the dentate gyrus of the in vitro guinea pig hippocampus: effect of combined deprivation of glucose and oxygen. J Neurosci Methods. 1988;28:147-154.
12. Lust WD, Arai H, Yasamoto Y, Whittingham TS, Djuricic B, Mrsulja BB, Passonneau JV. Ischemic encefalopathy. In: McCandless DM, ed. Cerebral Energy Metabolism and Metabolic Encefalopathy. New York, NY: Plenum; 1985:79-177.
13. Calabresi P, Magarinos Ascone C, Centonze D, Pisani A, Sancesario G, D'Angelo V, Bernardi G. Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons. J Neurosci. 1997;17:1940-1949.
14. Horikawa H, Armstrong WE. A versatile means of intracellular labeling: injection of biocytin and its detection with avidin conjugates. J Neurosci Methods. 1988;25:1-11.
15. Kawaguchi Y. Physiological, morphological and histochemical characterization of three classes of interneurons in the rat neostriatum. J Neurosci. 1993;13:4908-4923.
16. Lev-Ram V, Miyakawa H, Lasser-Ross N, Ross WN. Calcium transients in cerebellar Purkinje neurons evoked by intracellular stimulation. J Neurophysiol. 1992;68:1167-1177.
17. Muri R, Knoepfel T. Activity induced elevations of intracellular calcium concentration in neurons of the deep cerebellar nuclei. J Neurophysiol. 1994;71:420-427.
18. Uematsu D, Greenberg JH, Reivich M, Karp A. In vivo measurement of cytosolic free calcium during cerebral ischemia and reperfusion. Ann Neurol. 1988;24:420-428.
19. McCormick DA, Connors BW, Lightall JW, Prince DA. Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex. J Neurophysiol. 1985;54:782-806.
20. Connors BW, Gutnick MJ, Prince DA. Electrophysiological properties of neocortical neurons in vitro. J Neurophysiol. 1982;48:1302-1320.
21. Ward A, Chaffman MO, Sorkin EM. Dantrolene: a review of its pharmacological and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs. 1986;32:130-168.
22. Lobner D, Lipton P. Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell damage. J Neurosci. 1993;13: 4861-4871.
23. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 1993;13:3510-3524.
24. Dubinski JM, Rothman SM. Intracellular calcium concentration during "chemical hypoxia" and excitotoxic neuronal injury. J Neurosci. 1991;11: 2545-2551.
25. 2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res. 1993;601:103-110.
26. 2+ elevation in cerebellar slices: a comparative study with the values found in hippocampal slices. Acta Neuropathol. 1995;89:2-7.
27. Goldberg MP, Weiss JW, Pham PC, Choi DW. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther. 1987;243:784-791.
28. Marcoux FW, Probert AW Jr, Weber ML. Hypoxic injury in cell culture: calcium accumulation blockade and neuroprotection by NMDA antagonists but not calcium-channel antagonists. In: Ginsberg MD, Dietrich WD, eds. Cerebrovascular Diseases. New York, NY: Raven Press; 1989:135-141.
29. Block GA, Pulsinelli WA. N-methyl-D-aspartate receptor antagonists: failure to prevent ischemia-induced selective neuronal damage. In: Powers WJ, Raichle ME, eds. Cerebrovascular Diseases (15th Princeton Research Conferences on Cerebrovascular Diseases). New York, NY: Raven Press; 1987:23-34.
30. Wieloch T, Gustafsson I, Westerberg E. Effects of the non-competitive NMDA receptor antagonist MK-801 on ischemic and hypoglycemic brain damage. In: Riss AR, ed. Frontiers in Excitatory Amino Acid Research. New York, NY: Raven Press; 1988:715-722.
31. Katsuta K, Nakanishi H, Shirakawa K, Yoshida K, Takagi K, Tamura A. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1995;15:345-348.
32. Nishikawa T, Kirsch JR, Koehler RC, Miyabe M, Traystman RJ. Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats. Stroke. 1994;25:2258-2264.
33. Hossmann KA. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol. 1994;4:23-26.
34. 2 deprivation in the central nervous system: on mechanisms of neuronal response, differential sensitivity and injury. Prog Neurobiol. 1993;40:277-318.
35. o. J Neurosci. 1993;13:63-72.
36. Bickler PE, Hansen BM. Causes of calcium accumulation in rat cortical brain slices during hypoxia and ischemia: role of ion channels and membrane damage. Brain Res. 1994;665:269-276.
37. Hoehner PJ, Blanck TJJ, Roy R, Rosenthal RE, Fiskum G. Alteration of voltage-dependent calcium channels in canine brain during global ischemia and reperfusion. J Cereb Blood Flow Metab. 1992;12:418-424.
38. Abe K, Kogure K, Watanabe T. Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN200-100). J Cereb Blood Flow Metab. 1988;8:436-439.
39. Steen PA, Gisvold SE, Milde JH. Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology. 1985;62: 406-414.
40. Uematsu D, Greenberg JH, Hickey WF, Reivich M. Nimodipine attenuates both increases in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke. 1989;20: 1531-1537.
41. Pringle AK, Benham CD, Sim L, Kennedy J, Iannotti F, Sundstrom LE. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke. 1996;27:2124-2130.
42. Grotta JC. Clinical aspects of the use of calcium channel antagonists in cerebrovascular disease. Clin Neuropharmacol. 1991;14:373-390.
43. Mohr JP, Orgogozo JM, Harrison MJG. Meta-analysis of nimodipine trials in acute ischemic stroke. Cerebrovasc Dis. 1994;14:373-390.
44. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of acute stroke studies involving selfotel treatment. ASSIST steering committed. Lancet. 1997;349:32.
45. Brott T. Thrombolysis for stroke. Arch Neurol. 1996;53:1305-1306.
46. Fisher M. Potentially effective therapies for acute ischemic stroke. Eur Neurol. 1995; 35:3-7.
47. del Zoppo GJ. Thrombolysis in acute stroke. Neurologia. 1995;10(suppl 2):37-47.